258 related articles for article (PubMed ID: 8315492)
41. Cell-specific sorting of biogenic amine transporters expressed in epithelial cells.
Gu HH; Ahn J; Caplan MJ; Blakely RD; Levey AI; Rudnick G
J Biol Chem; 1996 Jul; 271(30):18100-6. PubMed ID: 8663573
[TBL] [Abstract][Full Text] [Related]
42. Lanthanides inhibit the human noradrenaline, 5-hydroxytryptamine and dopamine transporters.
Bryan-Lluka LJ; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):699-706. PubMed ID: 9205953
[TBL] [Abstract][Full Text] [Related]
43. In vivo microdialysis for measurement of extracellular monoamine levels following inhibition of monoamine transporters.
Chen NH; Reith ME
Methods Enzymol; 1998; 296():719-30. PubMed ID: 9779485
[No Abstract] [Full Text] [Related]
44. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.
Gu H; Wall SC; Rudnick G
J Biol Chem; 1994 Mar; 269(10):7124-30. PubMed ID: 8125921
[TBL] [Abstract][Full Text] [Related]
45. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
Vaidyanathan G; Affleck DJ; Zalutsky MR
J Nucl Med; 1995 Apr; 36(4):644-50. PubMed ID: 7699460
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
Tatsumi M; Groshan K; Blakely RD; Richelson E
Eur J Pharmacol; 1997 Dec; 340(2-3):249-58. PubMed ID: 9537821
[TBL] [Abstract][Full Text] [Related]
47. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.
Buck J; Bruchelt G; Girgert R; Treuner J; Niethammer D
Cancer Res; 1985 Dec; 45(12 Pt 1):6366-70. PubMed ID: 3864530
[TBL] [Abstract][Full Text] [Related]
48. Expression of norepinephrine and serotonin transporter mRNAs in the rat superior cervical ganglion.
Nishimura M; Sato K; Shimada S; Tohyama M
Brain Res Mol Brain Res; 1999 Apr; 67(1):82-6. PubMed ID: 10101235
[TBL] [Abstract][Full Text] [Related]
49. Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain.
Rothman RB; Katsnelson M; Vu N; Partilla JS; Dersch CM; Blough BE; Baumann MH
Eur J Pharmacol; 2002 Jun; 447(1):51-7. PubMed ID: 12106802
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and transporter binding properties of (R)-2 beta, 3 beta- and (R)-2 alpha, 3 alpha-diaryltropanes.
Jiang S; Chang AC; Abraham P; Kuhar MJ; Carroll FI
Bioorg Med Chem Lett; 1998 Dec; 8(24):3689-92. PubMed ID: 9934496
[TBL] [Abstract][Full Text] [Related]
51. Human placental monoamine transporters as targets for amphetamines.
Ramamoorthy JD; Ramamoorthy S; Leibach FH; Ganapathy V
Am J Obstet Gynecol; 1995 Dec; 173(6):1782-7. PubMed ID: 8610762
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis, and monoamine transporter binding site affinities of methoxy derivatives of indatraline.
Gu XH; Yu H; Jacobson AE; Rothman RB; Dersch CM; George C; Flippen-Anderson JL; Rice KC
J Med Chem; 2000 Dec; 43(25):4868-76. PubMed ID: 11123996
[TBL] [Abstract][Full Text] [Related]
53. Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants.
Galli A; DeFelice LJ; Duke BJ; Moore KR; Blakely RD
J Exp Biol; 1995 Oct; 198(Pt 10):2197-212. PubMed ID: 7500004
[TBL] [Abstract][Full Text] [Related]
54. Functional coupling of serotonin and noradrenaline transporters.
Horschitz S; Hummerich R; Schloss P
J Neurochem; 2003 Aug; 86(4):958-65. PubMed ID: 12887693
[TBL] [Abstract][Full Text] [Related]
55. Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors.
Olivier B; Soudijn W; van Wijngaarden I
Prog Drug Res; 2000; 54():59-119. PubMed ID: 10857386
[TBL] [Abstract][Full Text] [Related]
56. Structural determinants of neurotransmitter transport using cross-species chimeras: studies on serotonin transporter.
Barker EL; Blakely RD
Methods Enzymol; 1998; 296():475-98. PubMed ID: 9779469
[No Abstract] [Full Text] [Related]
57. Localization of norepinephrine and serotonin transporter in mouse brain capillary endothelial cells.
Wakayama K; Ohtsuki S; Takanaga H; Hosoya K; Terasaki T
Neurosci Res; 2002 Oct; 44(2):173-80. PubMed ID: 12354632
[TBL] [Abstract][Full Text] [Related]
58. Interferon-gamma-induced differentiation of human neuroblastoma cells increases cellular uptake and halflife of metaiodobenzylguanidine.
Montaldo PG; Carbone R; Cornaglia Ferraris P; Ponzoni M
Cytotechnology; 1993; 11 Suppl 1():S140-3. PubMed ID: 7763744
[TBL] [Abstract][Full Text] [Related]
59. The effect of 6-substituted-4',4"-difluorobenztropines on monoamine transporters and the muscarinic M1 receptor.
Grundt P; Kopajtic TA; Katz JL; Newman AH
Bioorg Med Chem Lett; 2004 Jun; 14(12):3295-8. PubMed ID: 15149693
[TBL] [Abstract][Full Text] [Related]
60. Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody.
Melikian HE; McDonald JK; Gu H; Rudnick G; Moore KR; Blakely RD
J Biol Chem; 1994 Apr; 269(16):12290-7. PubMed ID: 8163533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
